BeCytes opens new laboratory to accelerate the production of in vitro cellular models 19/06/2025 Healthcare Access to innovation BeCytes Biotechnologies, a company specialized in the research and development of in vitro cellular models, has launched... Partners - BeCytes Biotechnologies
Advanced Therapies Congress 2026 ExCeL, London United Kingdom Del 17/03/2026 to 18/03/2026 Access to innovation
Theriva™ Biologics Announces Presentation of Data from VCN-01 Retinoblastoma Phase 1 Clini... 04/06/2025 Healthcare Access to innovation Safety and clinical outcomes of Phase 1 study of VCN-01 (zabilugene almadenorepvec) in refractory retinoblastoma... Partners - THERIVA BIOLOGICS S.L.
Genetics Becomes an Ally for Healthcare Professionals 03/06/2025 Healthcare Access to innovation Digitalization Personalized medicine is no longer a promise—it's a reality, with genetics as its key ally. To bring this knowledge into... Partners - ADNTRO GENETICS SL
BCN HEALTH publishes a study highlighting the substantial healthcare costs associated with... 03/06/2025 Healthcare Access to innovation BCN HEALTH has published the study ‘Hepatocellular carcinoma: what are the differential costs compared to the general... Partners - BCN Health
Accelerating molecular discovery using an in silico design platform 08/07/2025 Healthcare Access to innovation Drug discovery Innovative drugs Advanced therapies Industrial biotechnology Join our free event on Tuesday, July 8th at the Parque Científico de Barcelona for an extended version of our Lunch and... Partners
Sodena leads BioSintNA, the Synthetic Biology Business Plan in Navarra 27/05/2025 Healthcare Access to innovation Navarre takes a strategic step toward the future with the launch of BioSintNA, an ambitious synthetic biology business... Partners - SODENA
aptaTargets transferred ApTOLL to Merck 26/05/2025 Healthcare Access to innovation Financing ApTOLL completed a Phase 1b/2 clinical trial for acute ischemic stroke with positive results. Merck to assume clinical... Partners - AptaTargets
ALLOX, the startup exploring allosterism to revolutionize drug development 22/05/2025 Healthcare Access to innovation Recently established at the Barcelona Science Park, ALLOX is harnessing cutting-edge technology that merges genetics... Partners - Parc Científic de Barcelona
